These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12643517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coasting. A viable option for patients at risk of ovarian hyperstimulation syndrome.
    Gafar AH, Abotalib ZM.
    Saudi Med J; 2002 Nov; 23(11):1398-401. PubMed ID: 12506304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.
    Abdalla H, Nicopoullos JD.
    Fertil Steril; 2010 Oct; 94(5):1757-63. PubMed ID: 19939366
    [Abstract] [Full Text] [Related]

  • 7. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception.
    Ulug U, Ben-Shlomo I, Bahceci M.
    Fertil Steril; 2004 Aug; 82(2):338-42. PubMed ID: 15302281
    [Abstract] [Full Text] [Related]

  • 8. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.
    Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM.
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B, Nguyen TA, Cheung AP, Leung PC.
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [Abstract] [Full Text] [Related]

  • 13. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P, Mátyás S, Kaali SG.
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characteristics of populations of granulosa cells from individual follicles in women undergoing 'coasting' during controlled ovarian stimulation (COS) for IVF.
    Tozer AJ, Iles RK, Iammarrone E, Nica RA, Gillott CM, Xusong W, Al-Shawaf T, Grudzinskas JG.
    Hum Reprod; 2004 Nov; 19(11):2561-8. PubMed ID: 15471924
    [Abstract] [Full Text] [Related]

  • 16. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 17. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T.
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [Abstract] [Full Text] [Related]

  • 18. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW, Maier DB, Nulsen JC, Benadiva CA.
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [Abstract] [Full Text] [Related]

  • 19. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ, Iles RK, Iammarrone E, Gillott CM, Al-Shawaf T, Grudzinskas JG.
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [Abstract] [Full Text] [Related]

  • 20. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER, Gómez-Palomares JL, Ricciarelli E.
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.